Showing results (181-190 of 1,283) with videos related to
Sort By:
Pageof 129
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 1, 1993
Cytomegalovirus: a virus of increasing relevance to oral medicine and pathologyJ Epstein, C ScullyTechniques in Coloproctology|May 4, 2005
Endoanal ultrasound-guided needle drainage of intersphincteric abscessJ Epstein, P GiordanoAmerican Journal of Hematology|September 1, 1988
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.Blood|May 1, 1980
Flow cytometry of DNA content in human bone marrow: a critical reappraisalG M Dosik, B Barlogie, W Göhde, et al.Investigational New Drugs|January 1, 1994
Phase II study of carboplatin (CBDCA) in refractory multiple myeloma. A Southwest Oncology Group studyB Barlogie, J Crowley, S E Salmon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1983
High-dose cytosine arabinoside in non-Hodgkin's lymphomaH Kantarjian, B Barlogie, W Plunkett, et al.Oncology (Williston Park, N.Y.)|November 1, 1994
Hemopoietic stem cell transplants for multiple myelomaS Jagannath, D H Vesole, G Tricot, et al.Cancer|October 15, 1987
Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapyB Têtu, R L Katz, S P Kalter, et al.Bone Marrow Transplantation|July 1, 1997
Peripheral stem cell mobilization and engraftment in patients over age 60S C Guba, D H Vesole, S Jagannath, et al.Blood|December 1, 1988
Prognostic factors with high-dose melphalan for refractory multiple myelomaB Barlogie, R Alexanian, L Smallwood, et al.Pageof 129